Search Results

There are 1514110 results for: content related to: Recurrent orbital inflammation in a patient with multiple sclerosis treated with interferon-beta

  1. You have free access to this content
    Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Irene Tramacere, Cinzia Del Giovane, Georgia Salanti, Roberto D'Amico and Graziella Filippini

    Published Online : 18 SEP 2015, DOI: 10.1002/14651858.CD011381.pub2

  2. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis

    Annals of Neurology

    Volume 39, Issue 3, March 1996, Pages: 285–294, Dr. Lawrence D. Jacobs, Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon, John R. Richert, Andres M. Salazar, Jill S. Fischer, Donald E. Goodkin, Carl V. Granger, Jack H. Simon, John J. Alam, David M. Bartoszak, Dennis N. Bourdette, Jonathan Braiman, Carol M. Brownscheidle, Michael E. Coats, Stanley L. Cohan, David S. Dougherty, Revere P. Kinkel, Michele K. Mass, Frederick E. Munschauer III, Roger L. Priore, Patrick M. Pullicino, Barbara J. Scherokman, Bianca Weinstock-Guttman and Ruth H. Whitham

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410390304

  3. Fingolimod for relapsing-remitting multiple sclerosis

    Intervention Review

    The Cochrane Library

    Loredana La Mantia, Irene Tramacere, Belal Firwana, Ilaria Pacchetti, Roberto Palumbo and Graziella Filippini

    Published Online : 19 APR 2016, DOI: 10.1002/14651858.CD009371.pub2

  4. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases

    Journal of Cutaneous Pathology

    Volume 36, Issue 3, March 2009, Pages: 331–337, Nigel J. Ball, Bryce J. Cowan and Stanley A. Hashimoto

    Version of Record online : 19 NOV 2008, DOI: 10.1111/j.1600-0560.2008.01019.x

  5. Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study

    European Journal of Neurology

    Volume 21, Issue 6, June 2014, Pages: 835–844, A. Shirani, Y. Zhao, M. E. Karim, J. Petkau, P. Gustafson, C. Evans, E. Kingwell, M. L. van der Kop, J. Oger and H. Tremlett

    Version of Record online : 18 DEC 2013, DOI: 10.1111/ene.12324

  6. Immunogenicity of recombinant human interferon beta interacting with particles of glass, metal, and polystyrene

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 1, January 2012, Pages: 187–199, Miranda M. C. Van Beers, Francesca Gilli, Huub Schellekens, Theodore W. Randolph and Wim Jiskoot

    Version of Record online : 14 SEP 2011, DOI: 10.1002/jps.22744

  7. Late form of early capsular block syndrome

    Clinical & Experimental Ophthalmology

    Volume 39, Issue 8, November 2011, Pages: 834–835, Jonathan Aboshiha, Charles Claoué and Daniel Gore

    Version of Record online : 29 JUN 2011, DOI: 10.1111/j.1442-9071.2011.02568.x

  8. Diffusion of interferon beta in Iran and its utilization in Tehran

    Pharmacoepidemiology and Drug Safety

    Volume 17, Issue 9, September 2008, Pages: 934–941, Mohammad Palesh, Pia Maria Jonsson, Hamidreza Jamshidi, Björn Wettermark, Göran Tomson and Sten Fredrikson

    Version of Record online : 28 MAY 2008, DOI: 10.1002/pds.1621

  9. You have free access to this content
    Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 397–407, P. S. Rommer, U. K. Zettl, B. Kieseier, H.-P. Hartung, T. Menge, E. Frohman, B. M. Greenberg, B. Hemmer and O. Stüve

    Version of Record online : 4 FEB 2014, DOI: 10.1111/cei.12206

  10. Management of patients with neutralizing antibodies against interferon-beta: stop IFN-beta therapy or wait for the antibodies to go away?

    European Journal of Neurology

    Volume 16, Issue 1, January 2009, Pages: 1–2, P. S. Sorensen

    Version of Record online : 8 DEC 2008, DOI: 10.1111/j.1468-1331.2008.02265.x

  11. You have free access to this content
    Cost-Effectiveness of Interferon Beta-1a, Interferon Beta-1b, and Glatiramer Acetate in Newly Diagnosed Non-primary Progressive Multiple Sclerosis

    Value in Health

    Volume 7, Issue 5, September 2004, Pages: 554–568, Lisa A. Prosser, Karen M. Kuntz, Amit Bar-Or and Milton C. Weinstein

    Version of Record online : 13 SEP 2004, DOI: 10.1111/j.1524-4733.2004.75007.x

  12. Effectiveness of interferon beta treatment in relapsing-remitting multiple sclerosis: an Italian cohort study

    Journal of Evaluation in Clinical Practice

    Volume 10, Issue 4, November 2004, Pages: 511–518, Pierluigi Russo, Andrea Paolillo, Luciano Caprino, Stefano Bastianello and Placido Bramanti

    Version of Record online : 8 OCT 2004, DOI: 10.1111/j.1365-2753.2003.00436.x

  13. You have free access to this content
    Cost-Effectiveness Analysis of Interferon Beta in Multiple Sclerosis: A Markov Process Analysis

    Value in Health

    Volume 5, Issue 1, January 2002, Pages: 44–54, Mark J. C. Nuijten and John Hutton

    Version of Record online : 21 MAR 2002, DOI: 10.1046/j.1524-4733.2002.51052.x

  14. You have free access to this content
    The Combination of Interferon-Beta and HMG-CoA Reductase Inhibition in Multiple Sclerosis: Enthusiasm Lost too Soon?

    CNS Neuroscience & Therapeutics

    Volume 16, Issue 6, December 2010, Pages: 362–373, Johann Sellner, Martin S. Weber, Patrick Vollmar, Heinrich P. Mattle, Bernhard Hemmer and Olaf Stüve

    Version of Record online : 9 NOV 2010, DOI: 10.1111/j.1755-5949.2010.00179.x

  15. Detection of Neutralizing Antibodies against Interferon Beta by Real-Time RT-PCR

    Detection and Quantification of Antibodies to Biopharmaceuticals: Practical and Applied Considerations

    Francesca Gilli, Antonio Bertolotto, Pages: 157–174, 2011

    Published Online : 20 JUN 2011, DOI: 10.1002/9781118075685.ch9

  16. Prediction of response to interferon therapy in multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 130, Issue 4, October 2014, Pages: 268–275, F. Sellebjerg, H. B. Søndergaard, N. Koch-Henriksen, P. S. Sørensen and A. B. Oturai

    Version of Record online : 18 JUN 2014, DOI: 10.1111/ane.12269

  17. Statins for multiple sclerosis

    Intervention Review

    The Cochrane Library

    Jin Wang, Yousheng Xiao, Man Luo and Hongye Luo

    Published Online : 7 DEC 2011, DOI: 10.1002/14651858.CD008386.pub3

  18. You have free access to this content
    Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

    Intervention Review

    The Cochrane Library

    Mohamed Mahdi-Rogers, Pieter A van Doorn and Richard AC Hughes

    Published Online : 14 JUN 2013, DOI: 10.1002/14651858.CD003280.pub4

  19. Alemtuzumab for multiple sclerosis

    Intervention Review

    The Cochrane Library

    Rachel Riera, Gustavo JM Porfírio and Maria R Torloni

    Published Online : 15 APR 2016, DOI: 10.1002/14651858.CD011203.pub2

  20. Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis

    European Handbook of Neurological Management, Second Edition, Volume 1, Second Edition

    P. Soelberg Sørensen, F. Deisenhammer, P. Duda, R. Hohlfeld, K.-M. Myhr, J. Palace, C. Polman, C. Pozzilli, C. Ross, Pages: 63–74, 2010

    Published Online : 6 SEP 2010, DOI: 10.1002/9781444328394.ch5